(1) Recently, The Michael J Fox Foundation made a significant disclosure with the revelation of a novel paper that confirmed the presence of a highly accurate biomarker for Parkinson's disease.

Researchers have discovered a new biomarker for Parkinson’s that could be used to identify people at risk of the disease and profoundly change the way it is treated. The assay for a particular ...

Parkinson's disease (PD ... It is, therefore, not surprising that many different candidate biomarkers for disease progression in PD have been studied. However, the literature in this area has ...

Rune Labs, which specializes in precision medicine for Parkinson’s disease (PD), has launched of a clinical program with ...

Other projects looking at digital biomarkers for Parkinson's include the crowd-sourced DREAM Challenge, which saw 40 research teams from around the world contribute ways to process accelerometer ...

Parkinson’s disease is best known for its effects on the central nervous system. In addition, recent scientific advances ...

In conclusion, while β-amyloid and tau abnormalities are not exclusive to Alzheimer’s, their presence remains highly relevant ...

The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to ...

New research has identified markers for frontotemporal dementia, a disease that's difficult to diagnose. Here's what experts ...